Deerfield Management Company, L.P. (Series C) Oncology Institute, Inc. Transaction History
Deerfield Management Company, L.P. (Series C)
- $5.37 Billion
- Q3 2025
A detailed history of Deerfield Management Company, L.P. (Series C) transactions in Oncology Institute, Inc. stock. As of the latest transaction made, Deerfield Management Company, L.P. (Series C) holds 3,360,052 shares of TOI stock, worth $13.3 Million. This represents 0.22% of its overall portfolio holdings.
Number of Shares
3,360,052
Previous 3,360,052
-0.0%
Holding current value
$13.3 Million
Previous $6.89 Million
70.24%
% of portfolio
0.22%
Previous 0.16%
Shares
3 transactions
Others Institutions Holding TOI
# of Institutions
112Shares Held
32.4MCall Options Held
490KPut Options Held
29.6K-
Vanguard Group Inc Valley Forge, PA4.55MShares$18 Million0.0% of portfolio
-
Center Book Partners LP Greenwich, CT2.7MShares$10.7 Million0.51% of portfolio
-
Balyasny Asset Management LLC Chicago, IL2.52MShares$10 Million0.01% of portfolio
-
Kanen Wealth Management LLC Coral Springs, FL1.84MShares$7.31 Million2.15% of portfolio
-
Kent Lake Capital LLC Mill Valley, CA1.75MShares$6.95 Million0.37% of portfolio
About Oncology Institute, Inc.
- Ticker TOI
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Care Facilities
- Shares Outstandng 73,495,504
- Market Cap $292M
- Description
- The Oncology Institute, Inc., an oncology company, provides medical oncology services in the United States. Its services include physician services, in-house infusion and dispensary, clinical trial services, radiation, outpatient stem cell transplants and transfusions programs, and patient support. The company also offers and manages clinical tr...